Insmed Incorporated (NASDAQ:INSM) is one of the best strong buy healthcare stocks to invest in. Mizuho cut the price target ...
Insmed Inc. (NASDAQ:INSM) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. On January 23, Roth/MKM began coverage of Insmed Inc. (NASDAQ:INSM) with a Buy rating and a $212 price ...
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest ...
Insmed (NASDAQ:INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. The drugmaker said 2024 revenue for Arikayce was approximately $363.7M, which ...
Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.54 EPS, expectations were $-1.07. Operator ...
CEO Will Lewis highlighted the strong start to 2025, driven by double-digit year-over-year revenue growth for ARIKAYCE and progress in mid to late-stage clinical programs. The FDA's review of the NDA ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of patients reported improvements to quality of life compared with placebo. Nontuberculous ...
Early Wednesday, Insmed Corp. provided a detailed debriefing of data from the phase II trial of Arikayce (previously Arikace), its inhaled liposomal amikacin, to treat patients with resistant ...
The first drug specifically to treat patients with Mycobacterium avium complex, a rare and chronic lung disease, has been approved by the FDA. Arikayce is also the first drug to be approved under the ...
BRIDGEWATER, N.J., March 23, 2021 /PRNewswire/ — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, ...
Insmed Incorporated 's ( INSM) shares skyrocketed 42.6% after it received breakthrough therapy designation for Arikayce from the FDA. The designation was granted to Arikayce for curing patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results